Published in Blood Weekly, March 9th, 2006
Under terms of the contract, the 2,500 members of VHA Inc. and University HealthSystem Consortium (UHC) can choose from several different options to acquire VersaTREK instrumentation and related media products.
Potential savings for Novation members can exceed 40%, and will depend on instrument requirements and method of acquisition.
"The VersaTREK instrument has established itself as a product that is unsurpassed in ease of use,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.